Interscalene nerve block with ropivacaine 0.5% versus ropivacaine 0.5% and Dexmedetomidine

A Prospective randomized and double blinded study comparing duration of post operative analgesia between ultrasound guided Interscalene block with Ropivacaine 0.5 percent and Interscalene block with Ropivacaine 0.5 percent and Dexmedetomidine as adjuvant for shoulder arthroscopic surgeries done under General anesthesia - Nil

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/04/084113

Enrollment

Registered

2025-04-04

Start date

Unknown

Completion date

Unknown

Last updated

2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Interscalene block : USG guided Interscalene block with Ropivacaine 0.5 percent Duration: 5 to 10 minutes Observation: 48 hours post procedure Control Intervention1: Interscalene block:

Eligibility

Inclusion criteria

Inclusion criteria: ASA Grade 1 and 2 Patients admitted for shoulder arthroscopic surgery

Exclusion criteria

Exclusion criteria: ASA grade 3 and 4 Pregnant and lactating mothers

Design outcomes

Primary

Measure	Time frame
To study the postoperative analgesia in Group A and B Timepoint: 30 minutes, 2 hours, 6 hours, 18 hours, 24 hours, 36 hours, 48 hours	—

Secondary

Measure	Time frame
To study the motor weakness & rescue analgesic requirementTimepoint: 30 minutes 2 hours 6 hours 18 hours 24 hours 36 hours 48 hours	—

Countries

India

Contacts

Public ContactDr Aravindh Veeresh

SRM institute of medical sciences

draanandshankar80@gmail.com9841440448

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026